Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 100 of 2051 entries
View as:

Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00984633 Org: User:
Start: 06/30/03 End: 12/31/03 Due: 12/31/04

A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)

Phase: N/A Priority: Normal
NCT ID: NCT01155479 Org: User:
Start: 07/06/10 End: 07/16/13 Due: 07/16/14

Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

Phase: N/A Priority: Normal
NCT ID: NCT01370642 Org: User:
Start: 06/27/11 End: 03/17/14 Due: 03/17/15

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Phase: N/A Priority: Normal
NCT ID: NCT04380636 Org: User:
Start: 07/06/20 End: 02/15/27 Due: 02/15/28

Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)

Phase: N/A Priority: Normal
NCT ID: NCT00289900 Org: User:
Start: 01/24/06 End: 08/06/10 Due: 08/06/11

A Clinical Study of Nemtabrutinib in Japanese Participants With Hematological Malignancies (MK-1026-002)

Phase: N/A Priority: Normal
NCT ID: NCT05673460 Org: User:
Start: 02/13/23 End: 03/30/26 Due: 03/30/27

Telemonitoring System Study in Participants With Type 2 Diabetes Mellitus (MK-0000-347)

Phase: N/A Priority: Normal
NCT ID: NCT02194608 Org: User:
Start: 12/31/11 End: 07/31/13 Due: 07/31/14

Analysis of the Peripheral Blood Mononuclear Cells of Patients With Ankylosing Spondylitis During Infliximab Treatment (Study P04465)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00778869 Org: User:
Start: 08/31/05 End: 08/31/05 Due: 08/31/06

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Phase: N/A Priority: Normal
NCT ID: NCT01076075 Org: User:
Start: 06/03/10 End: 01/19/12 Due: 01/19/13

A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)

Phase: N/A Priority: Normal
NCT ID: NCT06580587 Org: User:
Start: 04/15/25 End: 12/19/25 Due: 12/19/26

Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001)

Phase: N/A Priority: Normal
NCT ID: NCT03515824 Org: User:
Start: 08/13/18 End: 02/18/20 Due: 02/18/21

A Study to Evaluate Infliximab in Subjects With Moderate-to-Severe Psoriasis Not Responding to Standard or Biologic Therapy (Study P04612)

Phase: N/A Priority: Normal
NCT ID: NCT00687401 Org: User:
Start: 06/30/06 End: 05/31/09 Due: 05/31/10

A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)

Phase: N/A Priority: Normal
NCT ID: NCT00231777 Org: User:
Start: 07/31/05 End: 11/30/05 Due: 11/30/06

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Phase: N/A Priority: Normal
NCT ID: NCT01606800 Org: User:
Start: 01/01/13 End: 01/26/15 Due: 01/26/16

ZOSTAVAX(R) Local Registration Trial (V211-019)

Phase: N/A Priority: Normal
NCT ID: NCT00444860 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)

Phase: N/A Priority: Normal
NCT ID: NCT00282386 Org: User:
Start: 12/23/99 End: 09/01/04 Due: 09/01/05

Multiple Attacks Study to Compare the Efficacy and Safety of MK-0974 With Placebo for Acute Migraine (MK-0974-031)

Phase: N/A Priority: Normal
NCT ID: NCT00483704 Org: User:
Start: 08/14/08 End: 03/25/09 Due: 03/25/10

A Study of Ascending Single Doses of Surotomycin in Healthy Participants (MK-4261-008)

Phase: N/A Priority: Normal
NCT ID: NCT02835105 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)

Phase: N/A Priority: Normal
NCT ID: NCT06701305 Org: User:
Start: 06/13/24 End: 02/18/25 Due: 02/18/26

Open, Pharmacokinetic Study of Caspofungin in Neonates and Infants (0991-058)

Phase: N/A Priority: Normal
NCT ID: NCT00330395 Org: User:
Start: 05/31/06 End: 10/31/06 Due: 10/31/07

A Study of MK-1088 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-1088-002)

Phase: N/A Priority: Normal
NCT ID: NCT05394350 Org: User:
Start: 07/07/22 End: 09/07/23 Due: 09/07/24

Ertugliflozin vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)

Phase: N/A Priority: Normal
NCT ID: NCT01999218 Org: User:
Start: 12/16/13 End: 04/18/17 Due: 04/18/18

A Clinical Study to Assess the Effect of Enlicitide on How the Body Processes Digoxin in Healthy Adult Participants (MK-0616-031)

Phase: N/A Priority: Normal
NCT ID: NCT06597760 Org: User:
Start: 10/07/24 End: 11/15/24 Due: 11/15/25

Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Genotype 1 Infection With Advanced Fibrosis (F3 and F4)

Phase: N/A Priority: Normal
NCT ID: NCT03143998 Org: User:
Start: 02/12/18 End: 01/12/19 Due: 01/12/20

A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Phase: N/A Priority: Normal
NCT ID: NCT01460719 Org: User:
Start: 01/24/12 End: 09/25/12 Due: 09/25/13